GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSMUSG00000030678.6 | MYC-associated zinc finger protein (purine-binding transcription factor) |
Zfp281
|
ENSMUSG00000041483.8 | zinc finger protein 281 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Maz | mm10_v2_chr7_-_127026479_127026496 | 0.80 | 5.4e-09 | Click! |
Zfp281 | mm10_v2_chr1_+_136624901_136624949 | 0.29 | 8.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_142657466 | 33.87 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr6_-_115762346 | 30.89 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr11_+_74619594 | 26.69 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chrX_-_136215443 | 22.07 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr6_+_134929089 | 21.36 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr14_-_70635946 | 19.46 |
ENSMUST00000022695.9
|
Dmtn
|
dematin actin binding protein |
chr17_+_29135056 | 18.85 |
ENSMUST00000087942.4
|
Rab44
|
RAB44, member RAS oncogene family |
chr7_-_143460989 | 18.58 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chrX_-_135210672 | 18.54 |
ENSMUST00000033783.1
|
Tceal6
|
transcription elongation factor A (SII)-like 6 |
chr17_+_48299952 | 17.54 |
ENSMUST00000170941.1
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr17_-_26201328 | 17.50 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr17_-_26201363 | 17.36 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr9_+_111019284 | 17.07 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr6_+_134929118 | 17.01 |
ENSMUST00000185152.1
ENSMUST00000184504.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr1_+_134182404 | 16.46 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chr5_+_122100951 | 16.40 |
ENSMUST00000014080.6
ENSMUST00000111750.1 ENSMUST00000139213.1 ENSMUST00000111751.1 ENSMUST00000155612.1 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr2_+_118111876 | 16.11 |
ENSMUST00000039559.8
|
Thbs1
|
thrombospondin 1 |
chr9_-_44288535 | 15.95 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr4_+_115059507 | 15.65 |
ENSMUST00000162489.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_+_95009852 | 15.30 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr4_-_88033328 | 14.84 |
ENSMUST00000078090.5
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chrX_-_7967817 | 14.83 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr12_-_76709997 | 14.60 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chrX_-_136203637 | 14.60 |
ENSMUST00000151592.1
ENSMUST00000131510.1 ENSMUST00000066819.4 |
Tceal5
|
transcription elongation factor A (SII)-like 5 |
chr7_-_142656018 | 14.07 |
ENSMUST00000178921.1
|
Igf2
|
insulin-like growth factor 2 |
chr3_+_114030532 | 14.03 |
ENSMUST00000123619.1
ENSMUST00000092155.5 |
Col11a1
|
collagen, type XI, alpha 1 |
chr4_+_46039202 | 13.89 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr7_-_24760311 | 13.71 |
ENSMUST00000063956.5
|
Cd177
|
CD177 antigen |
chr11_+_87794206 | 13.48 |
ENSMUST00000121303.1
|
Mpo
|
myeloperoxidase |
chr7_-_142659482 | 13.44 |
ENSMUST00000121128.1
|
Igf2
|
insulin-like growth factor 2 |
chrX_+_8271642 | 13.37 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr16_+_4594683 | 13.21 |
ENSMUST00000014447.6
|
Glis2
|
GLIS family zinc finger 2 |
chr7_-_142578093 | 13.05 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr15_-_77755218 | 12.92 |
ENSMUST00000070911.2
|
Apol8
|
apolipoprotein L 8 |
chr14_-_60086832 | 12.61 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr4_-_134018829 | 12.58 |
ENSMUST00000051674.2
|
Lin28a
|
lin-28 homolog A (C. elegans) |
chr11_-_102088471 | 12.33 |
ENSMUST00000017458.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr11_+_24080664 | 12.12 |
ENSMUST00000118955.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr15_-_73184840 | 11.79 |
ENSMUST00000044113.10
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr5_-_122050102 | 11.72 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr8_+_57455898 | 11.63 |
ENSMUST00000034023.3
|
Scrg1
|
scrapie responsive gene 1 |
chr11_+_116531744 | 11.54 |
ENSMUST00000106387.2
ENSMUST00000100201.3 |
Sphk1
|
sphingosine kinase 1 |
chr17_+_28769307 | 11.49 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chr5_+_137288273 | 11.23 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr19_-_24555819 | 11.01 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
Pip5k1b
|
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
chr15_-_82224330 | 11.01 |
ENSMUST00000089161.2
ENSMUST00000109535.2 |
Tnfrsf13c
|
tumor necrosis factor receptor superfamily, member 13c |
chr8_+_22974844 | 10.88 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr12_+_109544498 | 10.88 |
ENSMUST00000126289.1
|
Meg3
|
maternally expressed 3 |
chr18_+_54422286 | 10.68 |
ENSMUST00000181269.1
|
Redrum
|
Redrum, erythroid developmental long intergenic non-protein coding transcript |
chr7_+_142498832 | 10.68 |
ENSMUST00000078497.8
ENSMUST00000105953.3 ENSMUST00000179658.1 ENSMUST00000105954.3 ENSMUST00000105952.3 ENSMUST00000105955.1 ENSMUST00000074187.6 ENSMUST00000180152.1 ENSMUST00000105950.4 ENSMUST00000105957.3 ENSMUST00000169299.2 ENSMUST00000105958.3 ENSMUST00000105949.1 |
Tnnt3
|
troponin T3, skeletal, fast |
chrX_-_136068236 | 10.48 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chr12_+_109452833 | 10.12 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr2_+_164940742 | 10.12 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr11_+_58918004 | 10.10 |
ENSMUST00000108818.3
ENSMUST00000020792.5 |
Btnl10
|
butyrophilin-like 10 |
chr7_+_117380937 | 10.08 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr7_+_96211656 | 10.05 |
ENSMUST00000107165.1
|
Tenm4
|
teneurin transmembrane protein 4 |
chrX_+_136270302 | 9.99 |
ENSMUST00000113112.1
|
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr11_+_4236411 | 9.97 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr2_-_91931675 | 9.88 |
ENSMUST00000111309.1
|
Mdk
|
midkine |
chr11_+_96931387 | 9.85 |
ENSMUST00000107633.1
|
Prr15l
|
proline rich 15-like |
chr11_+_95010277 | 9.82 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chrX_-_73659724 | 9.76 |
ENSMUST00000114473.1
ENSMUST00000002087.7 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr5_-_122049822 | 9.75 |
ENSMUST00000111752.3
|
Cux2
|
cut-like homeobox 2 |
chr12_+_109545390 | 9.75 |
ENSMUST00000146701.1
|
Meg3
|
maternally expressed 3 |
chr7_+_143005046 | 9.64 |
ENSMUST00000009396.6
|
Tspan32
|
tetraspanin 32 |
chr2_+_131186942 | 9.61 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr11_+_87793470 | 9.57 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr15_+_80173642 | 9.53 |
ENSMUST00000044970.6
|
Mgat3
|
mannoside acetylglucosaminyltransferase 3 |
chr17_-_35066170 | 9.52 |
ENSMUST00000174190.1
ENSMUST00000097337.1 |
AU023871
|
expressed sequence AU023871 |
chr10_+_75564086 | 9.47 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_-_28621932 | 9.42 |
ENSMUST00000028156.7
ENSMUST00000164290.1 |
Gfi1b
|
growth factor independent 1B |
chr13_-_51793650 | 9.41 |
ENSMUST00000110040.2
ENSMUST00000021900.7 |
Sema4d
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
chr17_+_43568096 | 9.40 |
ENSMUST00000167214.1
|
Pla2g7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
chr2_+_84734050 | 9.40 |
ENSMUST00000090729.2
|
Ypel4
|
yippee-like 4 (Drosophila) |
chrX_+_136270253 | 9.33 |
ENSMUST00000178632.1
ENSMUST00000053540.4 |
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr12_+_109549157 | 9.29 |
ENSMUST00000128458.1
ENSMUST00000150851.1 |
Meg3
|
maternally expressed 3 |
chr11_+_11684967 | 9.29 |
ENSMUST00000126058.1
ENSMUST00000141436.1 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr4_+_115057410 | 9.25 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_-_102082464 | 9.20 |
ENSMUST00000100398.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr2_-_164779721 | 9.05 |
ENSMUST00000103095.4
|
Tnnc2
|
troponin C2, fast |
chr2_-_131562283 | 9.00 |
ENSMUST00000103184.3
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr13_-_49248663 | 8.98 |
ENSMUST00000135784.1
ENSMUST00000021816.5 |
Susd3
|
sushi domain containing 3 |
chr7_-_142576492 | 8.96 |
ENSMUST00000140716.1
|
H19
|
H19 fetal liver mRNA |
chr11_+_117797660 | 8.95 |
ENSMUST00000106331.1
|
6030468B19Rik
|
RIKEN cDNA 6030468B19 gene |
chr1_-_182019927 | 8.84 |
ENSMUST00000078719.6
ENSMUST00000111030.3 ENSMUST00000177811.1 ENSMUST00000111024.3 ENSMUST00000111025.2 |
Enah
|
enabled homolog (Drosophila) |
chr6_+_141249161 | 8.84 |
ENSMUST00000043259.7
|
Pde3a
|
phosphodiesterase 3A, cGMP inhibited |
chr11_+_87793722 | 8.78 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr8_+_3665747 | 8.69 |
ENSMUST00000014118.2
|
1810033B17Rik
|
RIKEN cDNA 1810033B17 gene |
chr10_-_127341583 | 8.66 |
ENSMUST00000026474.3
|
Gli1
|
GLI-Kruppel family member GLI1 |
chr9_-_56635624 | 8.66 |
ENSMUST00000114256.1
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr2_-_91931696 | 8.63 |
ENSMUST00000090602.5
|
Mdk
|
midkine |
chr5_+_76840597 | 8.62 |
ENSMUST00000120639.2
ENSMUST00000163347.1 ENSMUST00000121851.1 |
C530008M17Rik
|
RIKEN cDNA C530008M17 gene |
chr2_-_91931774 | 8.61 |
ENSMUST00000069423.6
|
Mdk
|
midkine |
chr5_-_134229581 | 8.59 |
ENSMUST00000111275.1
ENSMUST00000016094.6 ENSMUST00000144086.1 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr7_-_135716374 | 8.56 |
ENSMUST00000033310.7
|
Mki67
|
antigen identified by monoclonal antibody Ki 67 |
chr2_+_173022360 | 8.56 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chr3_+_131110350 | 8.55 |
ENSMUST00000066849.6
ENSMUST00000106341.2 ENSMUST00000029611.7 |
Lef1
|
lymphoid enhancer binding factor 1 |
chr7_-_38107490 | 8.52 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr3_-_98859774 | 8.50 |
ENSMUST00000107016.3
ENSMUST00000149768.1 |
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
chrX_-_111463149 | 8.46 |
ENSMUST00000096348.3
ENSMUST00000113428.2 |
Rps6ka6
|
ribosomal protein S6 kinase polypeptide 6 |
chr7_-_4752972 | 8.46 |
ENSMUST00000183971.1
ENSMUST00000182173.1 ENSMUST00000182738.1 ENSMUST00000184143.1 ENSMUST00000182111.1 ENSMUST00000182048.1 ENSMUST00000063324.7 |
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr7_-_142578139 | 8.39 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr2_-_156839790 | 8.38 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr14_+_54640952 | 8.37 |
ENSMUST00000169818.2
|
Gm17606
|
predicted gene, 17606 |
chr4_+_11191726 | 8.35 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr11_-_69617879 | 8.32 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr17_-_29237759 | 8.30 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chrX_+_8271381 | 8.29 |
ENSMUST00000033512.4
|
Slc38a5
|
solute carrier family 38, member 5 |
chr14_+_80000292 | 8.26 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr6_-_49214954 | 8.22 |
ENSMUST00000031838.7
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr7_+_24462475 | 8.15 |
ENSMUST00000002284.9
|
Plaur
|
plasminogen activator, urokinase receptor |
chr11_-_118129219 | 8.15 |
ENSMUST00000106308.3
ENSMUST00000084803.5 |
Dnah17
|
dynein, axonemal, heavy chain 17 |
chr8_+_72761868 | 8.08 |
ENSMUST00000058099.8
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr3_-_98859753 | 8.08 |
ENSMUST00000029465.6
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
chr7_+_110773658 | 7.98 |
ENSMUST00000143786.1
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr7_-_133123770 | 7.96 |
ENSMUST00000164896.1
ENSMUST00000171968.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr4_+_134315112 | 7.95 |
ENSMUST00000105875.1
ENSMUST00000030638.6 |
Trim63
|
tripartite motif-containing 63 |
chr11_-_46312220 | 7.95 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr7_-_142666816 | 7.93 |
ENSMUST00000105935.1
|
Igf2
|
insulin-like growth factor 2 |
chr2_+_84988194 | 7.90 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr17_-_23645264 | 7.88 |
ENSMUST00000024696.7
|
Mmp25
|
matrix metallopeptidase 25 |
chr14_+_54476100 | 7.88 |
ENSMUST00000164766.1
ENSMUST00000164697.1 |
Rem2
|
rad and gem related GTP binding protein 2 |
chr11_+_24078022 | 7.87 |
ENSMUST00000000881.6
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr9_-_44288332 | 7.85 |
ENSMUST00000161408.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr7_+_140093388 | 7.82 |
ENSMUST00000026540.8
|
Prap1
|
proline-rich acidic protein 1 |
chrX_-_36989656 | 7.82 |
ENSMUST00000060474.7
ENSMUST00000053456.4 ENSMUST00000115239.3 |
Sept6
|
septin 6 |
chr17_+_48247759 | 7.81 |
ENSMUST00000048065.5
|
Trem3
|
triggering receptor expressed on myeloid cells 3 |
chr11_+_94990996 | 7.74 |
ENSMUST00000038696.5
|
Ppp1r9b
|
protein phosphatase 1, regulatory subunit 9B |
chr14_-_98169542 | 7.71 |
ENSMUST00000069334.7
ENSMUST00000071533.6 |
Dach1
|
dachshund 1 (Drosophila) |
chr11_+_61956779 | 7.69 |
ENSMUST00000049836.7
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr7_+_142471838 | 7.69 |
ENSMUST00000038946.2
|
Lsp1
|
lymphocyte specific 1 |
chr4_+_136172367 | 7.69 |
ENSMUST00000061721.5
|
E2f2
|
E2F transcription factor 2 |
chr2_+_31245801 | 7.66 |
ENSMUST00000000199.7
|
Ncs1
|
neuronal calcium sensor 1 |
chr7_-_133123160 | 7.65 |
ENSMUST00000166439.1
|
Ctbp2
|
C-terminal binding protein 2 |
chr4_-_3938354 | 7.61 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr6_+_115774538 | 7.59 |
ENSMUST00000075995.5
|
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative) |
chr4_-_118620763 | 7.57 |
ENSMUST00000071972.4
|
Wdr65
|
WD repeat domain 65 |
chr11_-_12037391 | 7.57 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr7_+_29134971 | 7.57 |
ENSMUST00000160194.1
|
Rasgrp4
|
RAS guanyl releasing protein 4 |
chr4_-_44168339 | 7.57 |
ENSMUST00000045793.8
|
Rnf38
|
ring finger protein 38 |
chr15_-_66948419 | 7.56 |
ENSMUST00000167817.1
|
Ndrg1
|
N-myc downstream regulated gene 1 |
chr3_-_152166230 | 7.56 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr10_-_128401218 | 7.55 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr19_-_45816007 | 7.54 |
ENSMUST00000079431.3
ENSMUST00000026247.6 ENSMUST00000162528.2 |
Kcnip2
|
Kv channel-interacting protein 2 |
chr3_+_88532314 | 7.52 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chrX_+_8271133 | 7.49 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chr13_-_37049203 | 7.49 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr10_+_75568648 | 7.46 |
ENSMUST00000134503.1
ENSMUST00000125770.1 ENSMUST00000128886.1 ENSMUST00000151212.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr6_+_128362919 | 7.45 |
ENSMUST00000073316.6
|
Foxm1
|
forkhead box M1 |
chr14_-_34201604 | 7.42 |
ENSMUST00000096019.2
|
Gprin2
|
G protein regulated inducer of neurite outgrowth 2 |
chr11_-_96005872 | 7.40 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chr1_+_134182150 | 7.39 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr6_-_136939566 | 7.39 |
ENSMUST00000154440.1
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr6_+_4747306 | 7.38 |
ENSMUST00000175823.1
ENSMUST00000176204.1 ENSMUST00000166678.1 |
Peg10
|
paternally expressed 10 |
chr3_+_108364882 | 7.37 |
ENSMUST00000090563.5
|
Mybphl
|
myosin binding protein H-like |
chr17_+_31208049 | 7.36 |
ENSMUST00000173776.1
|
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr7_-_25072287 | 7.36 |
ENSMUST00000003468.8
|
Grik5
|
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
chr7_-_25005895 | 7.34 |
ENSMUST00000102858.3
ENSMUST00000080882.6 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chrX_+_144688907 | 7.33 |
ENSMUST00000112843.1
|
Zcchc16
|
zinc finger, CCHC domain containing 16 |
chr11_-_102365111 | 7.32 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr2_-_132029845 | 7.31 |
ENSMUST00000028814.8
|
Rassf2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr2_+_25242929 | 7.31 |
ENSMUST00000114355.1
ENSMUST00000060818.1 |
Rnf208
|
ring finger protein 208 |
chr1_-_172219715 | 7.30 |
ENSMUST00000170700.1
ENSMUST00000003554.4 |
Casq1
|
calsequestrin 1 |
chr6_+_127887582 | 7.28 |
ENSMUST00000032501.4
|
Tspan11
|
tetraspanin 11 |
chr3_+_108383829 | 7.28 |
ENSMUST00000090561.3
ENSMUST00000102629.1 ENSMUST00000128089.1 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr2_+_36216749 | 7.26 |
ENSMUST00000147012.1
ENSMUST00000122948.1 |
Gm13431
|
predicted gene 13431 |
chr16_-_42340595 | 7.25 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr17_-_25433775 | 7.24 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr2_-_153444441 | 7.22 |
ENSMUST00000109784.1
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr17_-_46629420 | 7.21 |
ENSMUST00000044442.8
|
Ptk7
|
PTK7 protein tyrosine kinase 7 |
chr3_-_100489324 | 7.18 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr17_+_26941420 | 7.17 |
ENSMUST00000081285.3
ENSMUST00000177932.1 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr19_+_8591254 | 7.16 |
ENSMUST00000010251.3
ENSMUST00000170817.1 |
Slc22a8
|
solute carrier family 22 (organic anion transporter), member 8 |
chr10_+_75568630 | 7.15 |
ENSMUST00000145928.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr12_-_101028983 | 7.14 |
ENSMUST00000068411.3
ENSMUST00000085096.3 |
Ccdc88c
|
coiled-coil domain containing 88C |
chr12_-_32953772 | 7.13 |
ENSMUST00000180391.1
ENSMUST00000181670.1 |
4933406C10Rik
|
RIKEN cDNA 4933406C10 gene |
chr12_-_109068173 | 7.12 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr2_-_170427828 | 7.12 |
ENSMUST00000013667.2
ENSMUST00000109152.2 ENSMUST00000068137.4 |
Bcas1
|
breast carcinoma amplified sequence 1 |
chr7_+_143005677 | 7.08 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
Tspan32
|
tetraspanin 32 |
chr4_+_130308595 | 7.07 |
ENSMUST00000070532.7
|
Fabp3
|
fatty acid binding protein 3, muscle and heart |
chr5_-_89883321 | 7.05 |
ENSMUST00000163159.1
ENSMUST00000061427.5 |
Adamts3
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
chr2_+_130295148 | 6.99 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr7_-_30821139 | 6.97 |
ENSMUST00000163504.1
|
Ffar2
|
free fatty acid receptor 2 |
chr17_+_47594629 | 6.95 |
ENSMUST00000182846.1
|
Ccnd3
|
cyclin D3 |
chr15_+_73723131 | 6.95 |
ENSMUST00000165541.1
ENSMUST00000167582.1 |
Ptp4a3
|
protein tyrosine phosphatase 4a3 |
chr8_-_80057989 | 6.94 |
ENSMUST00000079038.2
|
Hhip
|
Hedgehog-interacting protein |
chr7_+_143005638 | 6.91 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
Tspan32
|
tetraspanin 32 |
chr18_-_32559914 | 6.86 |
ENSMUST00000174000.1
ENSMUST00000174459.1 |
Gypc
|
glycophorin C |
chr3_+_14886426 | 6.86 |
ENSMUST00000029078.7
|
Car2
|
carbonic anhydrase 2 |
chr2_+_30834972 | 6.85 |
ENSMUST00000113592.2
|
Prrx2
|
paired related homeobox 2 |
chr5_-_137741601 | 6.85 |
ENSMUST00000119498.1
ENSMUST00000061789.7 |
Nyap1
|
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
chr10_+_43579161 | 6.83 |
ENSMUST00000058714.8
|
Cd24a
|
CD24a antigen |
chrX_-_150813637 | 6.79 |
ENSMUST00000112700.1
|
Maged2
|
melanoma antigen, family D, 2 |
chr11_-_102107822 | 6.78 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr10_-_5805412 | 6.77 |
ENSMUST00000019907.7
|
Fbxo5
|
F-box protein 5 |
chr6_+_148047259 | 6.75 |
ENSMUST00000032443.7
|
Far2
|
fatty acyl CoA reductase 2 |
chr15_+_40655020 | 6.74 |
ENSMUST00000053467.4
|
Zfpm2
|
zinc finger protein, multitype 2 |
chr10_+_75568641 | 6.74 |
ENSMUST00000131565.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr3_-_89338005 | 6.74 |
ENSMUST00000029674.7
|
Efna4
|
ephrin A4 |
chr8_+_93810832 | 6.74 |
ENSMUST00000034198.8
ENSMUST00000125716.1 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.6 | 31.8 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
10.5 | 31.5 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
9.7 | 77.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
7.6 | 30.5 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
7.2 | 21.5 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
6.6 | 19.8 | GO:0030221 | basophil differentiation(GO:0030221) |
6.6 | 19.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
6.5 | 25.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
6.5 | 19.4 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.7 | 37.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
4.6 | 37.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
4.6 | 13.9 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
4.4 | 13.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
4.3 | 12.8 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
3.9 | 27.0 | GO:0030421 | defecation(GO:0030421) |
3.8 | 11.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
3.7 | 18.3 | GO:0035989 | tendon development(GO:0035989) |
3.6 | 21.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
3.5 | 13.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
3.4 | 10.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
3.3 | 13.4 | GO:0031296 | B cell costimulation(GO:0031296) |
3.3 | 20.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.3 | 13.2 | GO:0060032 | notochord regression(GO:0060032) |
3.2 | 12.7 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
3.2 | 3.2 | GO:0035844 | cloaca development(GO:0035844) |
3.0 | 18.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
3.0 | 30.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.9 | 23.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.9 | 8.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.9 | 8.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.9 | 11.4 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.8 | 8.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
2.8 | 5.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.8 | 16.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.8 | 8.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.8 | 11.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.7 | 24.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.7 | 5.5 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.7 | 8.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
2.7 | 26.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.6 | 20.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.5 | 7.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.5 | 7.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.5 | 14.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.5 | 9.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
2.4 | 14.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.4 | 7.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
2.4 | 9.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
2.4 | 7.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.4 | 7.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.4 | 7.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.4 | 11.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.3 | 9.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
2.3 | 30.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.3 | 7.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
2.3 | 18.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.3 | 4.6 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
2.2 | 4.5 | GO:0015675 | nickel cation transport(GO:0015675) |
2.2 | 6.7 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.2 | 6.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.2 | 22.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.2 | 6.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
2.2 | 6.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.2 | 8.7 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.2 | 4.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.1 | 10.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.1 | 2.1 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
2.1 | 17.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
2.1 | 21.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.1 | 6.3 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.1 | 2.1 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
2.1 | 12.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
2.1 | 6.2 | GO:0060369 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
2.0 | 2.0 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.0 | 6.1 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
2.0 | 36.4 | GO:0015816 | glycine transport(GO:0015816) |
2.0 | 6.0 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
2.0 | 7.9 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
2.0 | 5.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
2.0 | 17.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 9.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.9 | 11.7 | GO:0032796 | uropod organization(GO:0032796) |
1.9 | 5.8 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.9 | 13.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.9 | 1.9 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
1.9 | 21.1 | GO:0071435 | potassium ion export(GO:0071435) |
1.9 | 17.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.9 | 9.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.9 | 7.5 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
1.9 | 7.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.9 | 3.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.9 | 5.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.9 | 7.5 | GO:0015840 | urea transport(GO:0015840) |
1.8 | 9.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.8 | 3.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.8 | 1.8 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
1.8 | 5.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.8 | 5.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.8 | 10.7 | GO:0006868 | glutamine transport(GO:0006868) |
1.8 | 7.1 | GO:0045575 | basophil activation(GO:0045575) |
1.8 | 26.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.8 | 8.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.8 | 5.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.7 | 8.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.7 | 6.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.7 | 5.1 | GO:0072278 | metanephric comma-shaped body morphogenesis(GO:0072278) |
1.7 | 6.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.7 | 47.3 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.7 | 5.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.7 | 10.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.7 | 5.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.6 | 9.9 | GO:0060022 | hard palate development(GO:0060022) |
1.6 | 4.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
1.6 | 8.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
1.6 | 3.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
1.6 | 6.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.6 | 3.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
1.6 | 1.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.6 | 4.8 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.6 | 1.6 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
1.5 | 6.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.5 | 10.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.5 | 7.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.5 | 7.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 1.5 | GO:0033058 | directional locomotion(GO:0033058) |
1.5 | 1.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
1.5 | 6.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.5 | 4.5 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.5 | 7.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.5 | 4.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.5 | 3.0 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
1.5 | 4.4 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.5 | 5.9 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
1.5 | 4.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.5 | 1.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.5 | 8.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.4 | 4.3 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
1.4 | 4.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.4 | 4.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.4 | 2.9 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.4 | 19.7 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.4 | 2.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.4 | 1.4 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.4 | 5.6 | GO:1902896 | terminal web assembly(GO:1902896) |
1.4 | 1.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.4 | 4.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.4 | 11.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 5.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
1.4 | 19.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.4 | 4.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
1.4 | 5.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 4.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.3 | 5.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.3 | 6.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.3 | 5.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.3 | 8.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.3 | 6.6 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.3 | 1.3 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.3 | 5.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.3 | 7.9 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.3 | 7.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.3 | 11.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 14.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.3 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
1.3 | 3.9 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
1.3 | 2.6 | GO:0051885 | positive regulation of anagen(GO:0051885) |
1.3 | 2.6 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
1.3 | 5.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.3 | 5.2 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
1.3 | 10.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.3 | 3.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.3 | 5.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.3 | 3.8 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.3 | 3.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.3 | 5.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.3 | 2.5 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
1.2 | 2.5 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.2 | 5.0 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.2 | 4.9 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
1.2 | 13.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
1.2 | 4.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.2 | 15.9 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
1.2 | 4.9 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.2 | 9.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.2 | 6.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.2 | 2.4 | GO:1990523 | bone regeneration(GO:1990523) |
1.2 | 4.8 | GO:0007494 | midgut development(GO:0007494) |
1.2 | 1.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.2 | 4.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.2 | 2.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
1.2 | 3.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.2 | 1.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
1.2 | 1.2 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
1.2 | 1.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.2 | 13.8 | GO:0002679 | respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) |
1.2 | 5.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.1 | 5.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.1 | 6.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.1 | 22.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.1 | 2.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.1 | 3.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.1 | 4.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.1 | 3.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.1 | 6.6 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 4.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 4.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
1.1 | 4.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.1 | 4.4 | GO:0032218 | riboflavin transport(GO:0032218) |
1.1 | 4.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.1 | 4.4 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
1.1 | 5.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.1 | 3.3 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
1.1 | 4.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 3.2 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
1.1 | 11.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 3.2 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.1 | 15.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.1 | 2.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.1 | 3.2 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
1.1 | 3.2 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.0 | 2.1 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
1.0 | 4.2 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.0 | 6.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.0 | 7.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.0 | 3.1 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
1.0 | 4.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
1.0 | 3.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.0 | 1.0 | GO:0032762 | mast cell cytokine production(GO:0032762) |
1.0 | 6.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
1.0 | 1.0 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
1.0 | 4.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.0 | 12.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.0 | 2.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.0 | 8.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.0 | 3.0 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
1.0 | 8.0 | GO:0015074 | DNA integration(GO:0015074) |
1.0 | 3.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.0 | 3.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.0 | 5.0 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) superior vena cava morphogenesis(GO:0060578) |
1.0 | 1.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.0 | 14.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 6.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.0 | 1.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.0 | 8.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 1.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 2.9 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.9 | 6.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.9 | 6.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 7.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 2.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.9 | 2.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.9 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.9 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 7.4 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.9 | 4.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.9 | 5.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 5.5 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.9 | 1.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 11.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.9 | 9.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.9 | 2.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 0.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.9 | 1.8 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.9 | 0.9 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.9 | 2.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 2.7 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.9 | 6.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.9 | 4.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.9 | 44.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.9 | 7.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.9 | 9.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.9 | 0.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.9 | 11.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.9 | 0.9 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.9 | 1.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.9 | 1.8 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.9 | 7.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.9 | 2.6 | GO:0051794 | regulation of catagen(GO:0051794) |
0.9 | 15.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.9 | 0.9 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.9 | 16.7 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 4.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 0.9 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.9 | 6.9 | GO:0034650 | aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.9 | 1.7 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
0.9 | 2.6 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.9 | 2.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.9 | 3.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.8 | 1.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 3.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.8 | 33.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.8 | 6.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 3.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.8 | 22.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.8 | 3.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.8 | 4.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 5.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 0.8 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.8 | 30.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.8 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 18.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.8 | 4.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.8 | 0.8 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.8 | 3.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.8 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.8 | 9.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.8 | 3.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.8 | 1.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 8.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.8 | 4.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.8 | 2.4 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.8 | 0.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.8 | 6.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.8 | 3.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.8 | 1.6 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.8 | 7.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.8 | 3.9 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.8 | 14.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 2.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 6.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.8 | 3.9 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.8 | 2.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.8 | 3.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 5.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 5.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.8 | 15.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.8 | 3.8 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 3.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 2.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.8 | 4.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 9.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 4.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 5.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 5.8 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.7 | 2.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.7 | 3.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.7 | 6.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 2.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.7 | 19.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 2.8 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.7 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 8.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 2.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.7 | 5.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 2.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 4.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 3.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.7 | 6.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 3.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.7 | 2.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 4.1 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.7 | 2.7 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.7 | 5.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.7 | 2.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.7 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.7 | 10.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.7 | 4.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 3.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.7 | 3.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.7 | 4.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.7 | 2.6 | GO:0015867 | ATP transport(GO:0015867) |
0.6 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 2.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 3.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 1.9 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.6 | 1.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 9.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.6 | 5.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 5.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.6 | 2.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.6 | 3.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 1.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 1.9 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.6 | 5.6 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.6 | 0.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.6 | 5.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.6 | 1.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.6 | 3.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.6 | 2.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 1.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.6 | 2.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.6 | 1.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 6.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 5.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.6 | 2.5 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.6 | 4.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.6 | 3.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.6 | 18.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.6 | 2.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.6 | 1.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 1.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 3.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 3.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 1.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.6 | 8.8 | GO:0030220 | platelet formation(GO:0030220) |
0.6 | 2.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.6 | 14.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 1.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.6 | 4.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 1.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.6 | 6.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 1.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.6 | 2.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 1.7 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.6 | 1.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.6 | 16.6 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.6 | 3.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.6 | 1.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.6 | 0.6 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.6 | 2.8 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 6.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.6 | 2.2 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.6 | 7.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 7.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.6 | 3.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 1.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 2.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 29.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.5 | 2.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.5 | 2.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.5 | 4.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.5 | 1.6 | GO:0042376 | menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 2.7 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.5 | 1.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 5.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 2.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 20.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.5 | 3.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 2.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 2.1 | GO:0010286 | heat acclimation(GO:0010286) |
0.5 | 4.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 2.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 8.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.5 | 2.1 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.5 | 1.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.5 | 2.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 2.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 3.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 2.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 1.5 | GO:0071846 | actin filament debranching(GO:0071846) |
0.5 | 4.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.5 | 3.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 3.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 2.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 3.6 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.5 | 1.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.5 | 2.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.5 | 1.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.5 | 2.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.5 | 1.5 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.5 | 8.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 1.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 2.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 1.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.5 | 2.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 4.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 5.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 2.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 1.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.5 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 1.9 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 2.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.5 | 3.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 1.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.5 | 3.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.5 | 7.7 | GO:0032095 | regulation of response to food(GO:0032095) |
0.5 | 1.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 2.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.5 | 1.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.5 | 1.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 2.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 1.0 | GO:1904749 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) |
0.5 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 3.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 2.4 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.5 | 1.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 10.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.5 | 1.9 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.5 | 13.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.9 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.5 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 11.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.5 | 1.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 0.5 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.5 | 1.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.5 | 0.5 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.5 | 3.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 2.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 14.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 0.5 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 1.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
0.5 | 1.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 5.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.5 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.5 | 0.9 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.4 | 3.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 3.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.4 | 0.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.4 | 1.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 1.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 1.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.4 | 2.6 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.4 | 3.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 0.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.4 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 9.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.4 | 3.9 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.4 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 1.3 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.4 | 6.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.4 | 2.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.4 | 5.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 0.8 | GO:0061317 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) blood vessel endothelial cell fate specification(GO:0097101) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.4 | 5.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 11.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 0.4 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.4 | 0.8 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.4 | 2.1 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.4 | 8.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 3.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 7.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 0.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.4 | 2.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 3.7 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.4 | 2.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.4 | 0.8 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 0.8 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.4 | 1.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 0.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 1.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.4 | 1.2 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.4 | 2.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.4 | 7.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 3.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 2.8 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.4 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 0.8 | GO:0060872 | semicircular canal development(GO:0060872) |
0.4 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 0.8 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 8.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.4 | 12.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 0.8 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 1.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.4 | 4.2 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.4 | 1.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.9 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) regulation of inward rectifier potassium channel activity(GO:1901979) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.4 | 2.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 5.3 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.4 | 4.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.4 | 1.9 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.4 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 0.8 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.4 | 0.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 1.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.4 | 1.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.4 | 0.4 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) |
0.4 | 16.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.4 | 6.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 1.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.4 | 0.7 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.4 | 1.5 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.4 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 0.4 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.4 | 1.5 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.4 | 3.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 1.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 0.7 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.4 | 5.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.4 | 1.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 2.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.4 | 5.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 8.9 | GO:0051298 | centrosome duplication(GO:0051298) |
0.4 | 4.3 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.4 | 0.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 4.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 4.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.4 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 1.0 | GO:0042148 | strand invasion(GO:0042148) |
0.3 | 5.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 10.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 0.7 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.3 | 4.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 1.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 7.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 8.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 2.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 2.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 4.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 1.0 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.3 | 3.7 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.3 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 2.6 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.3 | 0.7 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 1.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 1.3 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.3 | 1.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 1.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.3 | 0.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.3 | 1.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 3.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 2.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.3 | 3.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 9.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 0.6 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.3 | 3.8 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.3 | 0.9 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.3 | 2.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 6.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 1.8 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 1.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 1.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 2.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 1.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.3 | 5.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 0.9 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.3 | 0.9 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 0.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 1.8 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 1.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 6.6 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.3 | 0.6 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.3 | 3.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 5.0 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 3.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.9 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.3 | 0.9 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.3 | 3.2 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.3 | 1.2 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.3 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 4.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.3 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.3 | 0.6 | GO:0019046 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.3 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.3 | 0.3 | GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.3 | 6.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.3 | 1.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 1.2 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.3 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.9 | GO:0072717 | response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
0.3 | 0.6 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 2.9 | GO:0032094 | response to food(GO:0032094) |
0.3 | 0.9 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 | 1.1 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.3 | 0.3 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.3 | 1.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 2.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 5.6 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 3.9 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 1.4 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.3 | 3.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 1.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 2.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 1.7 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.3 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 0.8 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 0.3 | GO:0099543 | trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
0.3 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.8 | GO:1903598 | angiotensin-mediated drinking behavior(GO:0003051) aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 0.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 5.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 1.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 0.3 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.3 | 0.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 0.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.3 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 5.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 3.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.3 | 0.3 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.3 | 1.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) positive regulation of vasculogenesis(GO:2001214) |
0.3 | 32.7 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.3 | 4.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 1.3 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.3 | 1.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.3 | 1.5 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 0.8 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.3 | 1.0 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.3 | 1.0 | GO:0090345 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.3 | 4.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 4.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.8 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.3 | 1.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.3 | 1.0 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.2 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 4.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.2 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 5.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 2.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.2 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.5 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.2 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 2.2 | GO:0002836 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 1.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.7 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.2 | 6.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 9.5 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.2 | 4.7 | GO:0030728 | ovulation(GO:0030728) |
0.2 | 0.7 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.2 | 3.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 1.6 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 5.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 3.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.2 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.9 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 1.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.7 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.2 | 1.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 1.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 3.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 7.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.6 | GO:0019085 | early viral transcription(GO:0019085) |
0.2 | 0.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 1.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 2.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 2.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 1.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 2.3 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.2 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 3.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.6 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.2 | 0.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 2.1 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 1.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 6.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 10.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 4.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.8 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.2 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 1.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 3.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.6 | GO:1902074 | response to salt(GO:1902074) cellular response to salt(GO:1902075) |
0.2 | 2.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 1.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 1.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.2 | 3.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.2 | 0.6 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.2 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.8 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.2 | 0.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 5.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 1.1 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.2 | 0.2 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 0.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.2 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 1.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 5.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 2.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 1.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 1.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 2.3 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.2 | 7.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 2.7 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.2 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 2.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.5 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 2.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 2.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 1.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.9 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.6 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 2.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 2.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.4 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 3.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 1.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 1.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) pericardium morphogenesis(GO:0003344) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 8.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 6.1 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.6 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.1 | 3.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 4.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 3.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.1 | GO:0003433 | growth plate cartilage chondrocyte development(GO:0003431) chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 3.1 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
0.1 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 2.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.7 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 1.2 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 1.3 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 3.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.5 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 0.4 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.1 | 3.5 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.4 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 2.3 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 2.2 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 2.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.8 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.7 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 1.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.7 | GO:1905214 | regulation of RNA binding(GO:1905214) |
0.1 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.7 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.7 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 1.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.1 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) regulation of antimicrobial humoral response(GO:0002759) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 1.1 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 1.3 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 1.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 2.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.1 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.7 | GO:0002718 | regulation of cytokine production involved in immune response(GO:0002718) |
0.1 | 0.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.3 | GO:0003283 | atrial septum development(GO:0003283) |
0.1 | 0.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 7.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:0007309 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.1 | 2.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 1.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 4.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 3.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 2.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.1 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 2.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.2 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.1 | 1.4 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.5 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.2 | GO:1900378 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 2.5 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.3 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.8 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 4.6 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 2.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 0.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.4 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.0 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.3 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.0 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.0 | 0.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.8 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.0 | GO:0031179 | peptide modification(GO:0031179) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.0 | 0.0 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.0 | 0.0 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 0.1 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.0 | 0.0 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.0 | 0.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.0 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 31.5 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
7.5 | 29.8 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
5.5 | 22.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
4.9 | 19.6 | GO:0014802 | terminal cisterna(GO:0014802) |
4.7 | 4.7 | GO:1902737 | dendritic filopodium(GO:1902737) |
3.6 | 10.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
3.6 | 14.6 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.1 | 9.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
3.1 | 9.3 | GO:0005940 | septin ring(GO:0005940) |
3.0 | 38.4 | GO:0044327 | dendritic spine head(GO:0044327) |
2.8 | 2.8 | GO:0034706 | sodium channel complex(GO:0034706) |
2.8 | 11.0 | GO:0043511 | inhibin complex(GO:0043511) |
2.7 | 10.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
2.6 | 12.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.5 | 45.8 | GO:0005861 | troponin complex(GO:0005861) |
2.4 | 9.7 | GO:0090537 | CERF complex(GO:0090537) |
2.1 | 6.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
2.0 | 18.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.0 | 9.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.8 | 7.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.8 | 9.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
1.8 | 3.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.8 | 28.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.8 | 12.3 | GO:0001740 | Barr body(GO:0001740) |
1.7 | 7.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.7 | 17.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.7 | 21.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 14.4 | GO:0042581 | specific granule(GO:0042581) |
1.6 | 4.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.5 | 9.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.5 | 4.4 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.5 | 10.2 | GO:0008091 | spectrin(GO:0008091) |
1.5 | 1.5 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.4 | 21.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.4 | 7.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.4 | 5.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.4 | 5.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.4 | 4.2 | GO:0042583 | chromaffin granule(GO:0042583) |
1.4 | 11.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.4 | 4.1 | GO:0072534 | perineuronal net(GO:0072534) |
1.4 | 2.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.4 | 16.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.4 | 8.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.4 | 5.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.3 | 4.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.3 | 6.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.3 | 9.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.3 | 5.2 | GO:0000235 | astral microtubule(GO:0000235) |
1.3 | 6.4 | GO:0031523 | Myb complex(GO:0031523) |
1.3 | 19.1 | GO:0036157 | outer dynein arm(GO:0036157) |
1.3 | 7.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.3 | 11.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.2 | 4.9 | GO:0060187 | cell pole(GO:0060187) |
1.2 | 19.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.2 | 10.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.2 | 4.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.2 | 1.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.2 | 3.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.2 | 30.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.1 | 3.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.1 | 3.2 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
1.1 | 3.2 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
1.1 | 10.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 3.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.0 | 9.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.0 | 2.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.0 | 2.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.9 | 5.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 3.8 | GO:0008623 | CHRAC(GO:0008623) |
0.9 | 13.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 5.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 6.2 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 35.5 | GO:0002102 | podosome(GO:0002102) |
0.9 | 12.4 | GO:0090543 | Flemming body(GO:0090543) |
0.9 | 52.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.9 | 9.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.9 | 3.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.9 | 6.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 17.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 2.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.8 | 3.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 18.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 7.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.8 | 21.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.8 | 11.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.8 | 14.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 8.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 3.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 0.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.8 | 6.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 8.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.8 | 13.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 2.3 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.8 | 15.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 1.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.8 | 9.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 5.3 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 3.0 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.7 | 3.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 5.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.7 | 4.4 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 2.2 | GO:0005595 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.7 | 2.9 | GO:0045160 | myosin I complex(GO:0045160) |
0.7 | 4.3 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 2.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 6.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 4.9 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.7 | 2.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 7.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.7 | 4.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 16.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.7 | 4.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 6.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 7.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 3.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.7 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 3.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 30.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 2.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.6 | 5.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.6 | 22.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 11.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 8.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.6 | 10.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 2.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 3.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 3.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 4.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 38.6 | GO:0005844 | polysome(GO:0005844) |
0.5 | 9.0 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.5 | 1.6 | GO:0035101 | FACT complex(GO:0035101) |
0.5 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 9.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 5.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 15.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 1.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 1.5 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 1.5 | GO:0031251 | PAN complex(GO:0031251) |
0.5 | 1.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 4.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 1.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.5 | 3.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 4.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 2.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 3.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 6.2 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 18.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 1.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 4.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.5 | 4.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 8.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 3.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 2.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 17.2 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 3.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.4 | 3.8 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 6.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 2.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 15.8 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 4.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 6.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 5.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 6.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.4 | 2.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 6.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 2.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 0.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.4 | 1.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 2.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 1.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 7.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 12.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 2.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 3.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 1.4 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.4 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 18.9 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 2.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 30.9 | GO:0005814 | centriole(GO:0005814) |
0.3 | 1.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 2.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 4.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 42.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 28.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 27.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.3 | 9.5 | GO:0031672 | A band(GO:0031672) |
0.3 | 1.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 6.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 2.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 4.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 1.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 4.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.3 | 2.8 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 9.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.3 | 1.7 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.3 | 6.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 3.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 10.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 2.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 5.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.5 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 26.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 1.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 19.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 8.8 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.2 | 3.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 12.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 15.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 4.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 6.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 2.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 14.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 8.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 2.3 | GO:0001741 | XY body(GO:0001741) |
0.2 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 8.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 3.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 3.5 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 3.2 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.2 | 6.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 12.6 | GO:0016605 | PML body(GO:0016605) |
0.2 | 2.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 17.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 4.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 4.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 2.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 3.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 29.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 0.5 | GO:0071920 | cleavage body(GO:0071920) |
0.2 | 9.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 1.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 3.0 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 2.5 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 7.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 6.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 13.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 2.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 4.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 5.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 2.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.8 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 1.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 2.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.2 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.1 | 0.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 4.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 2.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 3.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 3.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 3.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 5.4 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.3 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 4.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 9.6 | GO:0014069 | postsynaptic density(GO:0014069) |
0.1 | 0.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 67.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 8.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 3.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 2.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 2.8 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 7.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 5.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 26.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
5.9 | 47.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
5.6 | 28.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.6 | 4.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
3.4 | 10.3 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
3.1 | 18.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
3.1 | 21.9 | GO:0031013 | troponin I binding(GO:0031013) |
2.8 | 8.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.7 | 8.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
2.7 | 10.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.7 | 13.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.7 | 18.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
2.7 | 8.0 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
2.6 | 7.9 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
2.6 | 10.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
2.6 | 12.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.6 | 30.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
2.5 | 7.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.5 | 7.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
2.5 | 34.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.4 | 22.0 | GO:0034711 | inhibin binding(GO:0034711) |
2.4 | 23.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.3 | 9.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
2.3 | 6.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
2.2 | 85.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.2 | 41.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.2 | 8.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.2 | 17.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
2.2 | 8.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.2 | 15.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
2.2 | 6.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.1 | 12.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.1 | 25.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.1 | 16.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
2.0 | 18.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.0 | 8.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.0 | 15.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.9 | 17.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.9 | 9.5 | GO:0043515 | kinetochore binding(GO:0043515) |
1.9 | 13.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.9 | 7.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.9 | 5.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.9 | 3.7 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
1.9 | 5.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.8 | 5.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.8 | 5.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.8 | 7.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.8 | 8.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.7 | 7.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.7 | 8.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.7 | 5.1 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
1.7 | 6.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.7 | 11.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.7 | 20.2 | GO:0005522 | profilin binding(GO:0005522) |
1.7 | 9.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.6 | 1.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.6 | 8.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.6 | 4.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.6 | 6.2 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.5 | 13.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.5 | 12.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.5 | 9.2 | GO:0015265 | urea channel activity(GO:0015265) |
1.5 | 12.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.5 | 8.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.5 | 4.4 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.5 | 22.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.5 | 23.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.5 | 11.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.4 | 4.3 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.4 | 10.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.4 | 11.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.4 | 12.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.4 | 4.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.4 | 5.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.4 | 6.8 | GO:0043532 | angiostatin binding(GO:0043532) |
1.3 | 8.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.3 | 4.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.3 | 10.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.3 | 4.0 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
1.3 | 3.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.3 | 13.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.3 | 11.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 5.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.2 | 11.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.2 | 2.5 | GO:0048030 | disaccharide binding(GO:0048030) |
1.2 | 5.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
1.2 | 12.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.2 | 7.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.2 | 9.8 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
1.2 | 12.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.2 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.2 | 5.8 | GO:1990188 | euchromatin binding(GO:1990188) |
1.2 | 2.3 | GO:0034046 | poly(G) binding(GO:0034046) |
1.2 | 21.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.1 | 3.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.1 | 6.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.1 | 3.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.1 | 2.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.1 | 1.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
1.1 | 7.9 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.1 | 5.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.1 | 5.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.1 | 6.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.1 | 4.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.1 | 3.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.1 | 4.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.1 | 5.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.1 | 2.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.1 | 12.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 41.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.0 | 4.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.0 | 3.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 26.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.0 | 10.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.0 | 3.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 4.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.0 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 1.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.9 | 2.8 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.9 | 5.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.9 | 2.8 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.9 | 4.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 3.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.9 | 3.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.9 | 5.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 6.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 4.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.9 | 16.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.9 | 5.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 3.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.9 | 4.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 2.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.9 | 9.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.9 | 6.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 6.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.9 | 2.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.9 | 49.5 | GO:0070888 | E-box binding(GO:0070888) |
0.8 | 5.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 2.5 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.8 | 4.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.8 | 1.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.8 | 5.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 3.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.8 | 4.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.8 | 7.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.8 | 3.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.8 | 3.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.8 | 14.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.8 | 12.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 2.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.8 | 17.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.8 | 2.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.8 | 6.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 9.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 5.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 3.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.8 | 3.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 2.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 5.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 14.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.7 | 6.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 12.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.7 | 2.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 5.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.7 | 1.4 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.7 | 2.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.7 | 20.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.7 | 9.9 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 3.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 7.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.7 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 2.1 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.7 | 4.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 2.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.7 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.7 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 2.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.7 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 5.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.7 | 13.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 6.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 9.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 2.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 21.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 3.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.6 | 3.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.6 | 4.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 4.5 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.6 | 4.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.6 | 23.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 1.9 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 20.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 2.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 3.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 4.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 3.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 2.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.6 | 10.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 25.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.6 | 33.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 1.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.6 | 4.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 11.6 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 2.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 6.3 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.6 | 2.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 17.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 4.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 6.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 2.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 6.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 25.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 3.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.5 | 4.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 0.5 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.5 | 2.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 3.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 10.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 11.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 2.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 8.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 3.5 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.5 | 5.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 4.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 3.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.5 | 2.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 1.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 13.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.5 | 1.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 1.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 9.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 2.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 3.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.5 | 3.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 1.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.5 | 1.4 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.5 | 15.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 7.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 7.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 10.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 2.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.5 | 1.4 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.5 | 1.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 3.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 1.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.4 | 2.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.4 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 19.0 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 5.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 9.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 0.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 9.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.4 | 19.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.4 | 2.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 2.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 3.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 2.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 0.8 | GO:0002135 | CTP binding(GO:0002135) sulfonylurea receptor binding(GO:0017098) |
0.4 | 1.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.4 | 28.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 1.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 1.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 3.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 2.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 3.9 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.4 | 14.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 5.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 1.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 1.1 | GO:1902271 | lithocholic acid binding(GO:1902121) D3 vitamins binding(GO:1902271) |
0.4 | 1.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 11.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 5.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 2.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 2.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 1.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 3.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 4.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 11.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 2.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.4 | 1.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 2.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.4 | 2.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 13.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.4 | 1.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 2.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.4 | 0.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 8.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 2.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 2.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 2.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 10.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 2.7 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 10.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 68.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 1.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.3 | 2.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 5.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.3 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.3 | 7.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.3 | 15.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 4.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 8.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 10.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 2.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 7.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 2.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 5.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 11.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 4.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.9 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.3 | 3.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 5.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 1.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 26.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 2.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 3.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 5.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 3.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 7.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 1.2 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.3 | 13.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.3 | 17.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 1.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 2.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 1.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 1.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.1 | GO:0044020 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 0.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 1.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 9.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 5.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 2.7 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 0.5 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.3 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 0.5 | GO:0070401 | NADP+ binding(GO:0070401) |
0.3 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 6.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 1.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 5.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 1.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.0 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.3 | 2.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 3.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 0.3 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.2 | 1.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 0.7 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.2 | 1.7 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 4.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.7 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 4.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 10.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 2.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.7 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 1.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 4.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.9 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.2 | 1.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 13.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 2.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 2.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.7 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.2 | 1.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 0.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.2 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 5.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.8 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 3.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 2.1 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 3.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.0 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 2.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 2.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 6.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.2 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 18.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 2.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 1.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 21.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 2.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 4.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 5.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.6 | GO:0030545 | receptor regulator activity(GO:0030545) |
0.1 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.4 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 11.9 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 5.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 12.9 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 1.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 2.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 2.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 3.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 2.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 2.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 3.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 8.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 3.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 2.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 4.8 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.9 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 17.6 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 3.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 5.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 3.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 1.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 1.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 7.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 39.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.8 | 16.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.6 | 6.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.6 | 25.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 55.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.1 | 27.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.0 | 38.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.0 | 3.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.9 | 79.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.9 | 38.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.9 | 61.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.8 | 18.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 6.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 12.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.8 | 1.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.7 | 4.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 39.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 77.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.7 | 19.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 25.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.7 | 8.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 10.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 28.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 16.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.6 | 21.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 12.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 26.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 4.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 26.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 13.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.6 | 4.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 9.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 34.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 3.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 9.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 19.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 14.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 13.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 1.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 4.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 2.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 6.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 10.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 15.7 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 4.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 8.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 26.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.4 | 7.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 7.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 14.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 11.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 6.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 3.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 2.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 27.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 19.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 4.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 7.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 6.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 12.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 7.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 1.5 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 3.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 8.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 14.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 15.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 2.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 14.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 3.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 3.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 5.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 5.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 4.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 10.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 6.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 3.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 3.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 3.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 3.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 24.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 7.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 2.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 6.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 62.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.8 | 9.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.5 | 80.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.5 | 16.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.4 | 11.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.4 | 36.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.4 | 20.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.3 | 24.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.2 | 2.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.2 | 10.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.2 | 15.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 17.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.1 | 11.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 44.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.9 | 17.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 21.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 14.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 17.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.8 | 11.4 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.8 | 4.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 16.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 11.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 35.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.7 | 30.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 11.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 9.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 19.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 2.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 4.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 8.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 5.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 7.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 33.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.6 | 7.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 5.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 6.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 13.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 15.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 8.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 5.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.6 | 4.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 19.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.6 | 16.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 17.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 28.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.6 | 5.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 23.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 7.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 3.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 6.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.5 | 14.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 12.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 15.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.5 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 9.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 20.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 8.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 15.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 48.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 10.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 3.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 41.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 8.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 11.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 10.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 8.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 23.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 3.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 4.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 2.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.4 | 7.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 1.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.4 | 6.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 4.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 18.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 10.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 9.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 16.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 7.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 5.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 18.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 13.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 7.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 5.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 6.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 5.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 14.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 11.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 4.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 24.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 15.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 9.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 4.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 28.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 0.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 4.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 6.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 23.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 19.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 2.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 0.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 15.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 6.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.9 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.5 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 6.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 4.0 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 2.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 14.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 3.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 4.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 2.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 1.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |